These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1704088)

  • 1. Mechanism of action of FK 506 and cyclosporin.
    Steinmann B; Superti-Furga A; Bruckner P
    Lancet; 1991 Feb; 337(8738):439. PubMed ID: 1704088
    [No Abstract]   [Full Text] [Related]  

  • 2. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin.
    Griffiths EJ; Halestrap AP
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):611-4. PubMed ID: 1706598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.
    Flanagan WM; Corthésy B; Bram RJ; Crabtree GR
    Nature; 1991 Aug; 352(6338):803-7. PubMed ID: 1715516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of action of cyclosporine: a perspective for the 90's.
    Halloran PF; Madrenas J
    Clin Biochem; 1991 Feb; 24(1):3-7. PubMed ID: 1711939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophilins and immunosuppression by cyclosporins and macrolide structures.
    Schreier MH
    Acta Derm Venereol Suppl (Stockh); 1994; 186():100. PubMed ID: 7521103
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.
    Rosen MK; Standaert RF; Galat A; Nakatsuka M; Schreiber SL
    Science; 1990 May; 248(4957):863-6. PubMed ID: 1693013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophilins and immunosuppression.
    Schreier MH
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S125. PubMed ID: 7686830
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of FK 506.
    Kay JE; Moore AL; Doe SE; Benzie CR; Schönbrunner R; Schmid FX; Halestrap AP
    Transplant Proc; 1990 Feb; 22(1):96-9. PubMed ID: 1689914
    [No Abstract]   [Full Text] [Related]  

  • 11. When worlds collide: immunosuppressants meet protein phosphatases.
    McKeon F
    Cell; 1991 Sep; 66(5):823-6. PubMed ID: 1716181
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosynthesis and mechanism of action of cyclosporins.
    Lawen A
    Prog Med Chem; 1996; 33():53-97. PubMed ID: 8776941
    [No Abstract]   [Full Text] [Related]  

  • 13. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressive dysphasia possibly related to FK506 in two liver transplant recipients.
    Reyes J; Gayowski T; Fung J; Todo S; Alessiani M; Starzl TE
    Transplantation; 1990 Dec; 50(6):1043-5. PubMed ID: 1701571
    [No Abstract]   [Full Text] [Related]  

  • 15. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of mitochondrial cyclophilin from bovine heart.
    Inoue T; Yoshida Y; Isaka Y; Tagawa K
    Biochem Biophys Res Commun; 1993 Feb; 190(3):857-63. PubMed ID: 7679902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding.
    Tropschug M; Wachter E; Mayer S; Schönbrunner ER; Schmid FX
    Nature; 1990 Aug; 346(6285):674-7. PubMed ID: 1696687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
    Zarnt T; Lang K; Burtscher H; Fischer G
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression. Convergence of drug action.
    Freedman RB
    Nature; 1989 Oct; 341(6244):692. PubMed ID: 2477712
    [No Abstract]   [Full Text] [Related]  

  • 20. Isomerase modification.
    Rakitzis ET
    Nature; 1989 Aug; 340(6232):351-2. PubMed ID: 2666859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.